Triaging early-stage lung cancer patients into non-surgical pathways: Who, when, and what?

Rameses Sroufe, Feng Ming Kong

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

More lung cancer patients are being diagnosed at an earlier stage due to improved diagnostic imaging techniques, a trend that is expected to accelerate with the dissemination of lung cancer screening. Surgical resection has always been considered the standard treatment for patients with early-stage non-small cell lung cancer (NSCLC). However, non-surgical treatment options for patients with early-stage NSCLC have evolved significantly over the past decade with many new and exciting alternative treatments now available. These alternative treatments include radiofrequency ablation (RFA), microwave ablation (MWA), percutaneous cryoablation therapy (PCT), photodynamic therapy (PDT) and external beam radiation therapy (EBRT), including stereotactic body radiation therapy (SBRT) and accelerated hypofractionated radiation therapy. We describe the established alternatives to surgical resection, their advantages and disadvantages, potential complications and efficacy. We then describe the optimal treatment approach for patients with early-stage NSCLC based on tumor operability, size and location. Finally, we discuss future directions and whether any alternative therapies will challenge surgical resection as the treatment of choice for patients with operable early-stage lung cancer.

Original languageEnglish (US)
Pages (from-to)438-447
Number of pages10
JournalTranslational Lung Cancer Research
Volume4
Issue number4
DOIs
StatePublished - Jan 1 2015

Fingerprint

Lung Neoplasms
Non-Small Cell Lung Carcinoma
Radiotherapy
Therapeutics
Cryosurgery
Photochemotherapy
Diagnostic Imaging
Complementary Therapies
Microwaves
Early Detection of Cancer
Neoplasms

Keywords

  • Central
  • Inoperable
  • Non-small cell lung cancer (NSCLC)
  • Operable
  • Radiofrequency ablation (RFA)
  • Stereotactic body radiation therapy (SBRT)
  • Surgery

ASJC Scopus subject areas

  • Oncology

Cite this

Triaging early-stage lung cancer patients into non-surgical pathways : Who, when, and what? / Sroufe, Rameses; Kong, Feng Ming.

In: Translational Lung Cancer Research, Vol. 4, No. 4, 01.01.2015, p. 438-447.

Research output: Contribution to journalArticle

@article{17d279fc78f147c68235d201eed22cbb,
title = "Triaging early-stage lung cancer patients into non-surgical pathways: Who, when, and what?",
abstract = "More lung cancer patients are being diagnosed at an earlier stage due to improved diagnostic imaging techniques, a trend that is expected to accelerate with the dissemination of lung cancer screening. Surgical resection has always been considered the standard treatment for patients with early-stage non-small cell lung cancer (NSCLC). However, non-surgical treatment options for patients with early-stage NSCLC have evolved significantly over the past decade with many new and exciting alternative treatments now available. These alternative treatments include radiofrequency ablation (RFA), microwave ablation (MWA), percutaneous cryoablation therapy (PCT), photodynamic therapy (PDT) and external beam radiation therapy (EBRT), including stereotactic body radiation therapy (SBRT) and accelerated hypofractionated radiation therapy. We describe the established alternatives to surgical resection, their advantages and disadvantages, potential complications and efficacy. We then describe the optimal treatment approach for patients with early-stage NSCLC based on tumor operability, size and location. Finally, we discuss future directions and whether any alternative therapies will challenge surgical resection as the treatment of choice for patients with operable early-stage lung cancer.",
keywords = "Central, Inoperable, Non-small cell lung cancer (NSCLC), Operable, Radiofrequency ablation (RFA), Stereotactic body radiation therapy (SBRT), Surgery",
author = "Rameses Sroufe and Kong, {Feng Ming}",
year = "2015",
month = "1",
day = "1",
doi = "10.3978/j.issn.2218-6751.2015.07.22",
language = "English (US)",
volume = "4",
pages = "438--447",
journal = "Translational Lung Cancer Research",
issn = "2226-4477",
publisher = "Society for Translational Medicine (STM)",
number = "4",

}

TY - JOUR

T1 - Triaging early-stage lung cancer patients into non-surgical pathways

T2 - Who, when, and what?

AU - Sroufe, Rameses

AU - Kong, Feng Ming

PY - 2015/1/1

Y1 - 2015/1/1

N2 - More lung cancer patients are being diagnosed at an earlier stage due to improved diagnostic imaging techniques, a trend that is expected to accelerate with the dissemination of lung cancer screening. Surgical resection has always been considered the standard treatment for patients with early-stage non-small cell lung cancer (NSCLC). However, non-surgical treatment options for patients with early-stage NSCLC have evolved significantly over the past decade with many new and exciting alternative treatments now available. These alternative treatments include radiofrequency ablation (RFA), microwave ablation (MWA), percutaneous cryoablation therapy (PCT), photodynamic therapy (PDT) and external beam radiation therapy (EBRT), including stereotactic body radiation therapy (SBRT) and accelerated hypofractionated radiation therapy. We describe the established alternatives to surgical resection, their advantages and disadvantages, potential complications and efficacy. We then describe the optimal treatment approach for patients with early-stage NSCLC based on tumor operability, size and location. Finally, we discuss future directions and whether any alternative therapies will challenge surgical resection as the treatment of choice for patients with operable early-stage lung cancer.

AB - More lung cancer patients are being diagnosed at an earlier stage due to improved diagnostic imaging techniques, a trend that is expected to accelerate with the dissemination of lung cancer screening. Surgical resection has always been considered the standard treatment for patients with early-stage non-small cell lung cancer (NSCLC). However, non-surgical treatment options for patients with early-stage NSCLC have evolved significantly over the past decade with many new and exciting alternative treatments now available. These alternative treatments include radiofrequency ablation (RFA), microwave ablation (MWA), percutaneous cryoablation therapy (PCT), photodynamic therapy (PDT) and external beam radiation therapy (EBRT), including stereotactic body radiation therapy (SBRT) and accelerated hypofractionated radiation therapy. We describe the established alternatives to surgical resection, their advantages and disadvantages, potential complications and efficacy. We then describe the optimal treatment approach for patients with early-stage NSCLC based on tumor operability, size and location. Finally, we discuss future directions and whether any alternative therapies will challenge surgical resection as the treatment of choice for patients with operable early-stage lung cancer.

KW - Central

KW - Inoperable

KW - Non-small cell lung cancer (NSCLC)

KW - Operable

KW - Radiofrequency ablation (RFA)

KW - Stereotactic body radiation therapy (SBRT)

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=84960095714&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960095714&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2218-6751.2015.07.22

DO - 10.3978/j.issn.2218-6751.2015.07.22

M3 - Article

AN - SCOPUS:84960095714

VL - 4

SP - 438

EP - 447

JO - Translational Lung Cancer Research

JF - Translational Lung Cancer Research

SN - 2226-4477

IS - 4

ER -